Sanofi· @sanofi · X·· 21 天前AI 评分42
AI 导读
在我们收购Blueprint Medicines之后,我们正在整合团队、知识和能力,以改善系统性肥大细胞增多症患者的生活。阅读Maria Roche的完整信函:https://spkl.io/60137kl4S
正文
Following our acquisition of Blueprint Medicines, we're uniting our teams, knowledge, and capabilities to improve the lives of people with systemic mastocytosis. Read the full letter from Maria Roche: https://spkl.io/60137kl4S
来源:Sanofi · x.com